Rocket Pharma

Forecast & Rating14 analysts currently cover Rocket Pharma, with about 42.9% giving a positive rating — meaning they expect the stock to rise. The average price target is $8.84, about 133.9% upside from the current price of $3.78. Price targets range from $3.00 to $15.00 — a wide spread, showing clear disagreement over just how much Rocket Pharma can rise. For you, this means institutional views on Rocket Pharma are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 14, 2026; for reference only and not investment advice.